Core Insights - The global chemical industry is experiencing a structural transformation in M&A activities, driven by portfolio pressures and operational execution capabilities rather than cyclical recovery or financial leverage [1][5][32] - In 2025, global chemical M&A activity showed signs of stabilization, with a year-on-year growth of 18%, surpassing the seven-year historical average [1][3] - The recovery in M&A is characterized by a concentration of large strategic transactions, with the top four deals accounting for 40% of the total M&A volume [3][4] Group 1: M&A Trends and Dynamics - The M&A landscape is increasingly selective, with a few large transactions driving overall growth while basic transaction activities remain stable [3][4] - Financial investors have seen a significant rebound in transaction activity, nearly doubling year-on-year, but this growth is primarily due to a few large investment projects [4][10] - North America and Europe dominate M&A activity, driven by restructuring and asset divestiture transactions, while Asia continues to support non-large transactions through local industry consolidation [4][15] Group 2: Regional Performance and Outlook - North America saw a 9% year-on-year increase in M&A activity, reaching $51.5 billion, with financial investors accounting for 23% of the total [19][21] - Europe experienced a 14% increase in M&A activity, totaling $38.8 billion, with financial investors leading 56% of the transactions [21][22] - Asia's M&A activity grew by 16% to $34 billion, primarily driven by local players, with over 90% of transactions coming from domestic buyers [25][26] Group 3: Strategic Focus and Value Creation - The focus for M&A in 2026 will shift towards operational improvements, with 61% to 84% of executives identifying product pricing optimization and structural adjustments as key value creation methods [13][14] - The success of M&A transactions will increasingly depend on the ability to manage complex situations and execute operational changes effectively [14][32] - Investors are advised to focus on assets with improvement potential, particularly those that can enhance profitability through operational management and strategic positioning [33][34]

Core Viewpoint - The global chemical new materials industry is experiencing a wave of mergers and acquisitions starting in 2026, indicating a trend towards consolidation and strategic realignment within the sector [2]. Group 1: Mergers and Acquisitions - Mitsubishi Chemical is transferring its synthetic resin emulsion business and acrylic emulsion business to Japan's Konishi [2]. - Zhejiang Longsheng has completed the acquisition of the remaining 37.57% stake in the world's largest textile dye supplier, Dystar Global Holdings, for a total consideration of $702 million (approximately 4.928 billion RMB) [2]. - China Shenhua has received approval from the China Securities Regulatory Commission for its acquisition of equity stakes in 12 target companies held by the State Energy Group and its wholly-owned subsidiary, marking the largest chemical acquisition case in A-shares [2]. Group 2: Major Acquisitions - China BlueStar announced a strategic acquisition of Elkem ASA's organic silicon business, using its entire shareholding in Elkem (338,338,536 shares) as consideration, valued at approximately 1.02 million USD [4]. - Henkel has acquired the specialty coatings company Stahl for €2.1 billion (approximately 17.2 billion RMB), ending Wendel's 20-year control over Stahl [5]. - Henkel also announced the acquisition of Swiss water-based specialty adhesive manufacturer ATP Adhesive Systems, which is expected to generate sales of approximately €270 million in the 2025 fiscal year [6]. - Honeywell is set to acquire Johnson Matthey's catalyst technology business for £1.325 billion (approximately 15.1 billion RMB), with a significant reduction in the original deal price due to market conditions and performance considerations [7][8].

Core Insights - Despite geopolitical turmoil and a slow industry recovery, investor trading activities are gradually gaining momentum, driven by a cautious and opportunistic strategy [1] Group 1: Global Chemical M&A Trends - The chemical industry has seen a rebound in M&A activity, with a 17% year-over-year increase in global chemical M&A transaction volume last year, indicating a shift towards an upward trend [3] - Strategic factors driving increased M&A activity include chemical capacity oversupply, weak demand in the chemical and downstream industries, the need for portfolio restructuring, and regional diversification [6] - In 2024, private equity faces pressure from historically high levels of dry powder, with a 5% decline expected for the first time in years, although levels remain high by historical standards [6] Group 2: Future Outlook for M&A - In 2025, corporate entities are expected to drive M&A activity, with over 60% of chemical executives believing that M&A activity will increase compared to 2024 [9][12] - The average holding period for private equity-backed companies has reached a historical high, with over 30% held for at least five years, indicating a need for asset disposals to meet limited partner return expectations [9] - Over 90% of North American respondents cite unfavorable or unclear transaction valuations as a major barrier to M&A in 2025, highlighting the disproportionate impact of uncertainty on private equity compared to corporate entities [12] Group 3: Sector Performance - Specialty chemicals are outperforming commodity chemicals, attracting strategic interest and achieving valuation premiums due to their high margins and resilient portfolios [13] - Commodity and intermediate chemical companies face margin compression and pricing pressures, often trading at a discount or through carve-out sales [13] Group 4: Transaction Structures and Financing - Innovative transaction structures, such as earnouts and phased closings, have become standard in the market, helping to bridge valuation gaps and hedge macro risks [14][15] - Despite stable interest rates, financing remains constrained, pushing companies towards smaller transactions or carve-outs rather than large deals [15] Group 5: Regional Insights - North America is experiencing a surge in M&A activity, driven by reshoring and supply chain security, with a projected 80% year-over-year increase in 2024 [21] - In Asia, M&A activity is expected to decline by approximately 27% in 2024, primarily due to economic weakness and reduced transaction willingness amid geopolitical tensions [22] - The Middle East is emerging as a significant buyer in global acquisitions, with sovereign wealth funds and state-owned enterprises playing a crucial role [25] Group 6: European Market Dynamics - In Europe, M&A activity is being driven by restructuring and ESG considerations, with a notable increase in corporate divestitures expected [26][27] - Companies in Europe face pressure to reshape their portfolios due to increased competition and the need for capital expenditure to modernize aging assets [27]

Core Insights - Global chemical industry M&A activity is significantly slowing down in 2024, with total completed transactions valued over $2.5 million dropping from $57.1 billion in 2023 to $45.3 billion in 2024, a decline of 21% [1] - The number of transactions decreased from 75 to 50, reflecting a broader challenge faced by the chemical industry [1] - Factors such as declining profitability, uncertain market outlook, and rising interest rates have severely weakened investor confidence [1] Group 1: Market Trends - The current market slowdown indicates that the chemical industry is facing wider challenges, with general chemical valuations remaining low and specialty chemical valuations continuing a downward trend since 2021 [1] - By the end of 2024, there are 29 announced but uncompleted transactions totaling $24 billion, a trend expected to continue into 2025 [1] Group 2: Regional Distribution - Asia's share of global chemical M&A activity decreased from 55.4% in 2023 to 48% in 2024, yet it remains the leader [2] - The United States saw a significant increase in share from 25.7% in 2023 to 40% in 2024, while Europe’s share fell from 18.9% to 12% due to weak investor interest [2] Group 3: Private Equity and Corporate Actions - Despite high financing costs, private equity firms remain active, completing 9 transactions in 2024, increasing their market share from 13.5% in 2023 to 18% in 2024 [2] - There is a noticeable increase in corporate spin-off cases in 2024, with major companies like DuPont and Honeywell advancing related plans [2] - The share of general chemical transactions continues to shrink, accounting for only 36% in 2024, significantly below the historical average of 50%, with no general chemical M&A transactions occurring in Europe throughout the year [2]